美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Corgi U.S. Biotech 2x Daily ETF

38.92

-1.3372-3.32%

成交量：969

成交額：3.78萬

市值：77.84萬

市盈率：- -

高：38.92

開：38.92

低：38.92

收：40.26

52周最高：42.22

52周最低：25.26

股本：2.00萬

流通股本：2.00萬

量比：2.72

換手率：4.85%

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

美銀證券：中國CXO行業受惠生物科技融資強勁上調藥明康德等目標價

重塑全球藥企版圖！阿斯利康擬洽購百時美施貴寶，或締造史上最大醫藥併購案

重塑全球藥企版圖！阿斯利康(AZN.US)擬洽購百時美施貴寶(BMY.US)，或締造史上最大醫藥併購案

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/XBIX"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XBIX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBIX\",,,,,undefined,":{"symbol":"XBIX","market":"US","secType":"STK","nameCN":"Corgi U.S. Biotech 2x Daily ETF","latestPrice":38.92,"timestamp":1787596068964,"preClose":40.2572,"halted":0,"volume":969,"delay":0,"changeRate":-0.03321641842949822,"floatShares":20000,"shares":20000,"eps":0,"marketStatus":"交易中","change":-1.3372,"latestTime":"08-24 14:35:59 EDT","open":38.9199,"high":38.92,"low":38.9199,"amount":37786.282908,"amplitude":0.000002,"askPrice":39.71,"askSize":200,"bidPrice":39.59,"bidSize":200,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1787601600000},"marketStatusCode":2,"adr":0,"exchange":"CBOE","adjPreClose":40.2572,"nav":39.14,"aum":782800,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":40.8,"preClose":40.2572,"latestTime":"19:36 EDT","volume":3,"amount":120.1544,"timestamp":1787355411675,"change":0.5428,"changeRate":0.013483,"amplitude":0},"volumeRatio":2.715479},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBIX\",,,,,undefined,":{"symbol":"XBIX","floatShares":20000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.715479,"shares":20000,"dividePrice":0,"high":38.92,"amplitude":0.000002,"preClose":40.2572,"low":38.9199,"week52Low":25.2639,"pbRate":"--","week52High":42.2188,"institutionHeld":0,"latestPrice":38.92,"eps":0,"divideRate":0,"volume":969,"delay":0,"ttmEps":0,"open":38.9199,"prevYearClose":25.42,"prevWeekClose":40.2572,"prevMonthClose":32.1639,"prevQuarterClose":37.7974,"fiveDayClose":37.5332,"twentyDayClose":33.9733},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBIX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBIX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBIX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBIX\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659138517","title":"美銀證券：中國CXO行業受惠生物科技融資強勁 上調藥明康德等目標價","url":"https://stock-news.laohu8.com/highlight/detail?id=2659138517","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659138517?lang=zh_tw&edition=fundamental","pubTime":"2026-08-13 12:41","pubTimestamp":1786596060,"startTime":"0","endTime":"0","summary":"模拟交易客户端美银证券发布研报称，受惠上半年全球及中国生物科技一级市场融资表现强劲，加上创新药对外授权交易持续活跃，预期研发活动将进一步加快，中国CRO/CDMO企业可望受惠。该行上调药明康德H股目标价由204.3港元至242港元，药明康德A股目标价由177.8元人民币至210.5元人民币，维持“买入”评级，因其增长能见度清晰。该行并上调药明康德2029至2035年收入估算介乎3%至7%，经调整纯利预测亦上调介乎3%至7%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkgg/2026-08-13/doc-inincxku3329313.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LFSC","PSCH","02359","IBRN","PSIL","XBIX","MEDI","FHLC","SMCO","SURI","APXH","WX","161027","CXO","IDNA","BMED","603259","BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656346866","title":"重塑全球藥企版圖！阿斯利康擬洽購百時美施貴寶，或締造史上最大醫藥併購案","url":"https://stock-news.laohu8.com/highlight/detail?id=2656346866","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656346866?lang=zh_tw&edition=fundamental","pubTime":"2026-08-03 07:30","pubTimestamp":1785713456,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，据知情人士透露，阿斯利康已就收购百时美施贵宝展开探讨，这桩超级交易若达成，将缔造全球规模最大的制药企业之一。阿斯利康市值超过百时美施贵宝百时美施贵宝正为其部分最核心产品面临专利保护到期做准备，包括抗凝药艾乐妥与抗癌药欧狄沃。两款产品合计约占百时美施贵宝销售额的一半。上周，百时美施贵宝公布季度销售额 130 亿美元，创历史最高。阿斯利康目前是伦敦证券交易所市值第二大的公司。","market":"us","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475024.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"重塑全球药企版图！阿斯利康拟洽购百时美施贵宝，或缔造史上最大医药并购案","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2242652126.USD","LU2237443465.HKD","XPH","LU1323610961.USD","IE0009355771.USD","LU0456855351.SGD","RXD","IEHS","IE00B5TLWC47.USD","BK4559","LU2237443549.SGD","LU1291159041.SGD","LU2272731600.USD","PILL","LU2456880835.USD","LU0432979614.USD","LU2237443622.USD","LU1093756325.SGD","BK4534","FTXH","JHMH","LU2237443978.SGD","BK4581","SYNB","LU1718418525.SGD","LU0061475181.USD","LU1032466523.USD","IE00B3T34201.USD","IE00BJT1NW94.SGD","XBIX","LU2473716301.USD","PPH","IE00BSNM7G36.USD","LU1992135472.HKD","LU2360032135.SGD","FHLC","LU2125154778.USD","AZN","LU0096364046.USD","RXL","LU1585245621.USD","MEDI","LU0029864427.USD","BMY","AZNH","IE00BFTCPJ56.SGD","IHE","LU2237443382.USD","CURE","FXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656468693","title":"重塑全球藥企版圖！阿斯利康(AZN.US)擬洽購百時美施貴寶(BMY.US)，或締造史上最大醫藥併購案","url":"https://stock-news.laohu8.com/highlight/detail?id=2656468693","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656468693?lang=zh_tw&edition=fundamental","pubTime":"2026-08-03 07:25","pubTimestamp":1785713101,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2456880835.USD","FXH","LU1670710661.SGD","FTXH","LU1989771016.USD","AZN","XPH","BK4581","IE00BFTCPJ56.SGD","PPH","LU0225771236.USD","BK4534","MEDI","IE00B3T34201.USD","LU1267930573.SGD","LU1074936037.SGD","LU0237698245.USD","LU1032466523.USD","BK4588","LU0456855351.SGD","LU2272731782.SGD","RXD","RXL","FHLC","IEHS","CURE","JHMH","LU0029864427.USD","LU0985481810.HKD","SYNB","LU1868836914.USD","IHE","IE00B5TLWC47.USD","LU2089984988.USD","BMY","LU2125154935.USD","IE00BFXG1179.USD","PILL","LU0096364046.USD","LU0306807586.USD","LU0058720904.USD","LU1868837136.USD","XBIX","IE00BSNM7G36.USD","AZNH","LU1670711123.USD","IE0009355771.USD","IE0002141913.USD","LU2596442595.SGD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/XBIX\",params:#limit:6,delay:false,,,undefined,":[]}}